Risperidone 0.5mg Tablet PCD Pharma Franchise Delhi

Risperidone 0.5mg Tablet Manufacturing Company Baddi

Risperidone 0.5mg Tablet Neuro Franchise Ahmedabad

Risperidone 0.5mg Tablet Pharma Supplier Mumbai

Risperidone 0.5mg Tablet Export Company Chennai
Risperidone 0.5mg Tablet Franchise Opportunity Hyd

Home/Products /risperidone-0-5mg-tablet

Risplom 0.5 Tablet

Composition : Risperidone (0.5mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹31/-

Risplom 0.5 Tablet contains Risperidone, an atypical antipsychotic medication used to treat a range of psychiatric disorders. It works by modulating the activity of neurotransmitters in the brain, particularly dopamine (D2) and serotonin (5-HT2) receptors, helping to balance mood, behavior, and cognition. The 0.5 mg strength is typically used as a starting dose for sensitive patients, the elderly, or for gradual titration in psychiatric conditions. Risperidone has proven efficacy in reducing psychotic symptoms such as delusions and hallucinations, stabilizing mood, and improving social functioning. It is commonly used as part of a long-term treatment plan under psychiatric supervision.

Read More

About the Product

Risplom 0.5 Tablet contains Risperidone, an atypical antipsychotic medication used to treat a range of psychiatric disorders. It works by modulating the activity of neurotransmitters in the brain, particularly dopamine (D2) and serotonin (5-HT2) receptors, helping to balance mood, behavior, and cognition. The 0.5 mg strength is typically used as a starting dose for sensitive patients, the elderly, or for gradual titration in psychiatric conditions. Risperidone has proven efficacy in reducing psychotic symptoms such as delusions and hallucinations, stabilizing mood, and improving social functioning. It is commonly used as part of a long-term treatment plan under psychiatric supervision.

Common side effects include drowsiness, dizziness, weight gain, fatigue, and mild gastrointestinal disturbances. Some patients may experience increased appetite, restlessness, or sleep disturbances. Extrapyramidal symptoms (involuntary muscle movements) can occur at higher doses. Rare but serious adverse effects include neuroleptic malignant syndrome, severe allergic reactions, significant changes in blood pressure, and high blood sugar or cholesterol levels. Long-term use may require monitoring of metabolic parameters and prolactin levels.

Risplom 0.5 Tablet is indicated for the treatment of schizophrenia, bipolar mania, and irritability associated with autism spectrum disorder. It may also be prescribed off-label for other psychiatric or behavioral conditions as advised by a psychiatrist.

Risplom 0.5 Tablet should only be taken under the supervision of a qualified psychiatrist. Abrupt discontinuation should be avoided to prevent withdrawal symptoms or relapse. Caution is advised in patients with a history of cardiovascular disease, seizures, diabetes, or kidney and liver impairment. It is not recommended during pregnancy or breastfeeding unless the potential benefits outweigh the risks. Alcohol and sedating medications should be avoided as they can increase drowsiness and impair judgment. Regular follow-up with the treating physician is essential to monitor therapeutic response and side effects, especially during dose adjustments.

Store Risplom 0.5 Tablet in a cool, dry place below 30°C. Protect from moisture and direct sunlight. Keep it in the original blister packaging and out of the reach of children. Do not use after the expiry date printed on the strip.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation